Literature DB >> 16834790

High volume and low concentration of anaesthetic solution in the perivascular interscalene sheath determines quality of block and incidence of complications.

P Pippa1, P Cuomo, A Panchetti, M Scarchini, G Poggi, M D'Arienzo.   

Abstract

BACKGROUND AND
OBJECTIVE: In the perivascular sheath of the brachial plexus, the volume of anaesthetic solution determines the quality of anaesthetic cover. Fibrous septa may divide the perivascular space into compartments, leading to inadequate diffusion of the anaesthetic solution. The aim of our study was to obtain good anaesthesia and less complications using high volume of low concentration anaesthetic solution, overcoming the obstacle of the septa with a double approach to the scalene sheath.
METHODS: Sixty patients scheduled for shoulder capsuloplasty received both Winnie interscalene brachial plexus block and Pippa proximal cranial needle approach. The patients were randomly assigned to two groups. A constant dose of local anaesthetic was administered to each group: Group I (30 patients) received high volume (60 mL of anaesthetic solution) and Group II (30 patients) received low volume of solution (30 mL of anaesthetic solution). Sensory and motor block in the upper limb and complications were evaluated.
RESULTS: In all the patients the quality of anaesthesia obtained at the surgical site was excellent. In Group I also the areas supplied by the medial cutaneous nerves of the arm and forearm, ulnar, median and radial nerves were blocked (P < 0.002). Complications were only observed in Group II and consisted of bradycardia and hypotension (66% of the patients) and phrenic nerve paresis (27% of the patients).
CONCLUSIONS: The lower concentration of the anaesthetic solution avoids complications while increased volume provides good analgesic cover. The combination of the Winnie interscalene plexus block and the Pippa proximal cranial needle approach should contribute to fill up the scalene sheath overcoming the septa obstacles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16834790     DOI: 10.1017/S0265021506001074

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  7 in total

1.  Comparison of 0.25% levobupivacaine and 0.25% bupivacaine for posterior approach interscalene brachial plexus block.

Authors:  Semih Baskan; Vildan Taspinar; Levent Ozdogan; Kemal Yetis Gulsoy; Gulcan Erk; Bayazit Dikmen; Nermin Gogus
Journal:  J Anesth       Date:  2010-02       Impact factor: 2.078

2.  Comparison of three concentrations of simplex lidocaine in local anesthesia for inguinal hernia mesh-repairs.

Authors:  L-J Ban; W-Z Lei; Y Liu; Y-P Gong; Y Zeng; L Yang; W Zhang
Journal:  Hernia       Date:  2011-04-06       Impact factor: 4.739

3.  Factors determining the doses of local anesthetic agents in unilateral inguinal hernia repair.

Authors:  H Kulacoglu; I Ozyaylali; D Yazicioglu
Journal:  Hernia       Date:  2009-06-03       Impact factor: 4.739

4.  Use of Femoral and Sciatic Nerve Block Combination in Severe Emphysematous Lung Disease for Femoral Popliteal Arterial Bypass Surgery.

Authors:  Onur Selvi; Olgar Bayserke; Serkan Tulgar
Journal:  Cureus       Date:  2018-02-02

5.  Comparison between two different concentrations of a fixed dose of ropivacaine in interscalene brachial plexus block for pain management after arthroscopic shoulder surgery: a randomized clinical trial.

Authors:  Seung Cheol Lee; Joon Ho Jeong; Seong Yeop Jeong; Sung Wan Kim; Chan Jong Chung; So Ron Choi; Jeong Ho Kim; Sang Yoong Park
Journal:  Korean J Anesthesiol       Date:  2020-08-21

6.  Determinants for the duration of a single-shot interscalene brachial plexus block: concentration vs. volume of local anesthetics.

Authors:  Seong-Hyop Kim
Journal:  Korean J Anesthesiol       Date:  2021-05-13

7.  Transient adverse neurologic effects of spinal pain blocks.

Authors:  Han-Il Lee; Yong-Sook Park; Tack-Geun Cho; Seung-Won Park; Jeong-Taik Kwon; Young-Baeg Kim
Journal:  J Korean Neurosurg Soc       Date:  2012-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.